As a full agonist at the two the CB1 and CB2 cannabinoid receptors, this chemical compound is classed being an analgesic medication. The analgesic outcomes of cannabinoid ligands, mediated by CB1 receptors are very well established in treatment of neuropathic soreness, and also most cancers agony and arthritis.JWH-018 makes outcomes in animals sim